LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹9.38 Cr | ₹21 Cr | ₹13 Cr | ₹12 Cr | ₹-47 Cr |
What is the latest Net Current Assets ratio of LYKA LABS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹9.38 Cr |
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹-47 Cr |
How is Net Current Assets of LYKA LABS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹9.38 Cr | -54.92 | |
| Mar2025 | ₹21 Cr | 61.52 | |
| Mar2024 | ₹13 Cr | 10.99 | |
| Mar2023 | ₹12 Cr | Positive | |
| Mar2022 | ₹-47 Cr | - | |
Compare Net Current Assets of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹298.7 Cr | -4.3% | 10.8% | -15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -4.3% |
10.8% |
-15.3% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses